This company listing is no longer active
CStone Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
CStone Pharmaceuticals has a total shareholder equity of CN¥603.7M and total debt of CN¥173.3M, which brings its debt-to-equity ratio to 28.7%. Its total assets and total liabilities are CN¥1.7B and CN¥1.1B respectively.
Key information
28.7%
Debt to equity ratio
CN¥173.27m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.03b |
| Equity | CN¥603.72m |
| Total liabilities | CN¥1.06b |
| Total assets | CN¥1.66b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2616's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥803.1M).
Long Term Liabilities: 2616's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥252.9M).
Debt to Equity History and Analysis
Debt Level: 2616 has more cash than its total debt.
Reducing Debt: 2616's debt to equity ratio has increased from 0% to 28.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2616 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 2616 has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 5.9% each year.